Status:
UNKNOWN
Short-term Function and Pain After Treatment for Dupuytren's Disease
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Dupuytren Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate short-term pain and function associated with percutaneous needle aponeurotomy (PNA) and injections of the enzyme collagenase clostridium histolyticum in patients with Dupuytre...
Detailed Description
Percutaneous needle aponeurotomy (PNA) and injections of the enzyme collagenase clostridium histolyticum are two non-invasive treatment options for patients with Dupuytren's disease. While PNA has bee...
Eligibility Criteria
Inclusion
- Adult
- Dupuytren's disease diagnosis
- Consented to either percutaneous needle aponeurotomy or Xiaflex injection (patient choice)
- Able to read/write/speak English
- Must have an email address
Exclusion
- Previous treatment for Dupuytren's disease
- Type 2 Diabetes Mellitus
- Pre-existing hand condition, previous hand surgery or trauma
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02301078
Start Date
July 1 2014
End Date
November 1 2017
Last Update
December 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre, Division of Plastic and Reconstructive Surgery
Toronto, Ontario, Canada, M4N 3M5